ES2154336T3 - Producto para el cuidado de la piel. - Google Patents

Producto para el cuidado de la piel.

Info

Publication number
ES2154336T3
ES2154336T3 ES95915156T ES95915156T ES2154336T3 ES 2154336 T3 ES2154336 T3 ES 2154336T3 ES 95915156 T ES95915156 T ES 95915156T ES 95915156 T ES95915156 T ES 95915156T ES 2154336 T3 ES2154336 T3 ES 2154336T3
Authority
ES
Spain
Prior art keywords
pct
product
skin care
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95915156T
Other languages
English (en)
Inventor
Udo Hoppe
Gerhard Sauermann
Volker Schreiner
Klaus-Michael Steiger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6513756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2154336(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Application granted granted Critical
Publication of ES2154336T3 publication Critical patent/ES2154336T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

PREPARACIONES TOPICAS CONTENIENDO UNO O VARIOS COMPUESTOS ELEGIDOS DEL GRUPO (A), QUE SE COMPONE DE RETINOLES, RETINALES, Y {BE}-CAROTENO EN COMBINACION CON UNO O VARIOS COMPUESTOS, ELEGIDOS DEL GRUPO (B), COMPUESTO DE UBIQUINONAS Y SUS DERIVADOS Y PLASTOQUINONAS Y SUS DERIVADOS.
ES95915156T 1994-03-25 1995-03-24 Producto para el cuidado de la piel. Expired - Lifetime ES2154336T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4410238A DE4410238A1 (de) 1994-03-25 1994-03-25 Hautpflegemittel

Publications (1)

Publication Number Publication Date
ES2154336T3 true ES2154336T3 (es) 2001-04-01

Family

ID=6513756

Family Applications (3)

Application Number Title Priority Date Filing Date
ES95914306T Expired - Lifetime ES2242958T3 (es) 1994-03-25 1995-03-24 Substancias activas y composiciones para el tratamiento de la xerosis senil.
ES95915156T Expired - Lifetime ES2154336T3 (es) 1994-03-25 1995-03-24 Producto para el cuidado de la piel.
ES95915157T Expired - Lifetime ES2166820T3 (es) 1994-03-25 1995-03-24 Sustancias activas o combinaciones de sustancias activas y preparados contra el envejecimiento de la piel.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES95914306T Expired - Lifetime ES2242958T3 (es) 1994-03-25 1995-03-24 Substancias activas y composiciones para el tratamiento de la xerosis senil.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95915157T Expired - Lifetime ES2166820T3 (es) 1994-03-25 1995-03-24 Sustancias activas o combinaciones de sustancias activas y preparados contra el envejecimiento de la piel.

Country Status (7)

Country Link
US (2) US5889062A (es)
EP (3) EP0751761B1 (es)
JP (3) JPH09510724A (es)
AT (3) ATE207342T1 (es)
DE (4) DE4410238A1 (es)
ES (3) ES2242958T3 (es)
WO (3) WO1995026182A1 (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744368B1 (fr) * 1996-02-02 1998-04-24 Fabre Pierre Dermo Cosmetique Composition dermocosmetique contenant du retinal
EP1007018B1 (de) * 1997-02-12 2003-10-08 MSE Pharmazeutika GmbH Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon inder behandlung von tinnitus
US5855893A (en) 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
US6503523B2 (en) 1998-05-07 2003-01-07 Gs Development A.B. Skin care agents containing combinations of active agents consisting of vitamin a derivatives and UBI- or plastoquinones
DE19839402A1 (de) * 1998-08-29 2000-03-02 Beiersdorf Ag Retinoide enthaltende Hautpflegemittel
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
DE19926156A1 (de) * 1999-06-09 2000-12-14 Beiersdorf Ag Haarkosmetische Zubereitungen insbesondere solche zur Verbesserung der Kämmbarkeit der Haare auf der Grundlage von Ubichinonen
DE19926167B4 (de) * 1999-06-09 2012-08-30 Henkel Ag & Co. Kgaa Aerosol-Stylingmittel auf Wasserbasis mit Biochinonen
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
DE19932197A1 (de) * 1999-07-09 2001-01-18 Neudecker Birgit Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung
DE19944137A1 (de) * 1999-09-15 2001-03-22 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
IT1307281B1 (it) * 1999-11-25 2001-10-30 Simonelli Giuseppe Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva,
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
KR100848997B1 (ko) * 2000-11-09 2008-07-30 데이고꾸세이약꾸가부시끼가이샤 시트 형태의 팩 제제
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US6806069B2 (en) * 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
ITRM20010044A1 (it) * 2001-01-29 2002-07-29 Sigma Tau Healthscience Spa Integratore alimentare ad effetto dimagrante.
DE10111053A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen
DE60211581D1 (de) * 2001-03-23 2006-06-29 Oreal Hautbehandlungsmittel enthaltend Fasern und Ubichinone
US20030031688A1 (en) * 2001-04-02 2003-02-13 Dipak Ghosh Cosmetic composition with improved skin moisturizing properties
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
US6699464B1 (en) 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
DE10145008A1 (de) * 2001-09-12 2003-03-27 Odenco Kosmetik Gmbh Kosmetische Wirkstoffzubereitung
DE10146802A1 (de) * 2001-09-22 2003-04-24 Beiersdorf Ag Vitaminhaltige Hautpflegeprodukte
DE10301632A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten
WO2004112689A2 (en) * 2003-06-23 2004-12-29 Transpharma Medical Ltd. Transdermal delivery system for cosmetic agents
JP2005041870A (ja) * 2003-07-10 2005-02-17 Nisshin Kyorin Pharmaceutical Co Ltd 外用剤
US20050036976A1 (en) * 2003-08-12 2005-02-17 Joel Rubin Topical skin care composition
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8105583B2 (en) * 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
CA3031283A1 (en) 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
US20050175559A1 (en) * 2004-02-10 2005-08-11 Pcr Technology Holdings, Lc Method and preparation for reducing skin hyperpigmentation
EP1651199A4 (en) * 2004-02-13 2008-08-20 Pcr Technology Holdings Lc PROCESS AND PREPARATION REDUCING IRRITATION AND / OR INFLAMMATORY SKIN REACTIONS IN HUMANS
DE102004032837A1 (de) 2004-07-02 2006-02-09 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
CA2603403A1 (en) * 2005-04-01 2006-10-12 Zymes, Llc Skin enrichment using coq10 as the delivery system
US8252326B2 (en) 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
WO2007009657A1 (en) * 2005-07-15 2007-01-25 Dsm Ip Assets B.V. Novel use of organic compounds
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
EP1797861A1 (en) 2005-12-16 2007-06-20 KPSS-Kao Professional Salon Services GmbH Composition for the permanent shaping of human hair
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
WO2007148831A1 (ja) * 2006-06-23 2007-12-27 Ajinomoto Co., Inc. 亜鉛を有効成分として含有するコラーゲン合成促進剤
TW200808365A (en) * 2006-06-23 2008-02-16 Ajinomoto Kk Collagen synthesis promoter containing zinc as the active ingredient
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
MX363435B (es) 2007-03-22 2019-03-22 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
WO2009002913A1 (en) * 2007-06-22 2008-12-31 Avicena Group, Inc. Use of creatine compounds to treat dermatitis
EP2022535A1 (en) 2007-08-07 2009-02-11 KPSS-Kao Professional Salon Services GmbH Composition for permanent shaping human hair
AU2009233785B2 (en) 2008-04-11 2015-08-20 Berg Llc Methods and use of inducing apoptosis in cancer cells
US20100010100A1 (en) * 2008-07-09 2010-01-14 Hinman Andrew W Dermatological compositions with anti-aging and skin even-toning properties
WO2010014361A1 (en) * 2008-07-30 2010-02-04 Edison Pharmaceuticals, Inc. Naphthoquinone compositions with anti-aging, anti- inflammatory and skin even-toning properties
EP2191863A1 (en) 2008-11-26 2010-06-02 KPSS-Kao Professional Salon Services GmbH Composition for the permanent shaping of human hair
BRPI1010576A2 (pt) 2009-05-11 2016-03-15 Berg Biosystems Llc métodos para tratamento de distúrbios oncológicos usando transferidores epimetabólicos, moléculas intracelulares multidimensionais ou influenciadores ambientais.
PT2544663T (pt) * 2010-03-12 2018-04-05 Berg Llc Formulações intravenosas de coenzima q10 (coq10) e métodos de uso da mesma
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
AU2012271274B2 (en) 2011-06-17 2017-07-27 Berg Llc Inhalable pharmaceutical compositions
SG11201508272YA (en) 2013-04-08 2015-11-27 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムｑ１０の連続注入によるがんの治療方法
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
WO2019022250A1 (ja) * 2017-07-28 2019-01-31 国立大学法人九州大学 水溶性有効成分の放出が制御された経皮吸収組成物
CA3183350A1 (en) * 2020-06-23 2021-12-30 Thomas M. Hitchcock Probiotic skin formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629409A (en) * 1969-04-29 1971-12-21 Roy Gregory Pain removing composition and process for preparing same
JPS58180410A (ja) * 1982-04-16 1983-10-21 Shiseido Co Ltd 化粧料
JPH01501153A (ja) * 1986-10-23 1989-04-20 アルバル・エッセ・ピ・ア ユビデカレノン類を含有する化粧品
ES2071081T3 (es) * 1990-06-11 1995-06-16 Idi Farmaceutici Spa Liposomas fosfolipidicos que contienen principios activos y un procedimiento para su obtencion.
US5378461A (en) * 1991-07-12 1995-01-03 Neigut; Stanley J. Composition for the topical treatment of skin damage
GR1002207B (en) * 1992-08-06 1996-03-27 Johnson & Johnson Consumer Skin care compositions containing imidazoles.

Also Published As

Publication number Publication date
ATE197897T1 (de) 2000-12-15
US5912272A (en) 1999-06-15
WO1995026180A1 (de) 1995-10-05
ES2242958T3 (es) 2005-11-16
DE4410238A1 (de) 1995-09-28
ES2166820T3 (es) 2002-05-01
EP0751762B1 (de) 2000-12-06
ATE296612T1 (de) 2005-06-15
ATE207342T1 (de) 2001-11-15
EP0751762A1 (de) 1997-01-08
DE59509751D1 (de) 2001-11-29
WO1995026181A1 (de) 1995-10-05
JPH09510723A (ja) 1997-10-28
US5889062A (en) 1999-03-30
DE59508891D1 (de) 2001-01-11
JPH09510724A (ja) 1997-10-28
DE59511002D1 (de) 2005-07-07
JPH09510725A (ja) 1997-10-28
EP0751761B1 (de) 2005-06-01
WO1995026182A1 (de) 1995-10-05
EP0751763B1 (de) 2001-10-24
EP0751763A1 (de) 1997-01-08
EP0751761A1 (de) 1997-01-08

Similar Documents

Publication Publication Date Title
ES2154336T3 (es) Producto para el cuidado de la piel.
NO971192D0 (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
KR950702966A (ko) 성장 호르몬의 방출을 촉진시키는 벤조 융합된 락탐(Benzo-fused lactams promote release of growth hormone)
ES2094034T3 (es) Composicion antiacneica para el tratamiento simultaneo de las capas superficiales y profundas de la piel, su utilizacion.
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
ES2132678T3 (es) Sal de nimesulido hidrosoluble y su utilizacion para el tratamiento de las afecciones inflamatorias.
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BG105275A (en) Tan-1057 derivatives
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
DK0443848T3 (da) Nyt antiulcermiddel
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ATE133066T1 (de) Körperpflegemittel
AU2567097A (en) Novel vitamin d analogues
AU4630599A (en) Perfume composition
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
GB9126874D0 (en) Medicaments
PL355113A1 (en) Novel fusidic acid derivatives
DE69323191D1 (de) Wasserlösliche retinoide
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.
YU104192A (sh) 2-(4-hidroksipiperiodino)-1-alkanol derivati

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 751762

Country of ref document: ES